SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 194 filers reported holding SEATTLE GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $46,567,000 | +16.8% | 237,989 | +1.4% | 0.02% | +11.1% |
Q2 2020 | $39,872,000 | +44.3% | 234,708 | -2.0% | 0.02% | +28.6% |
Q1 2020 | $27,633,000 | +3.5% | 239,516 | +2.5% | 0.01% | +40.0% |
Q4 2019 | $26,690,000 | +34.2% | 233,587 | +0.2% | 0.01% | +25.0% |
Q3 2019 | $19,888,000 | +24.4% | 233,195 | +0.9% | 0.01% | +33.3% |
Q2 2019 | $15,986,000 | -2.9% | 231,055 | +2.8% | 0.01% | -14.3% |
Q1 2019 | $16,463,000 | +30.7% | 224,831 | +1.1% | 0.01% | +16.7% |
Q4 2018 | $12,596,000 | -30.5% | 222,333 | -5.4% | 0.01% | -14.3% |
Q3 2018 | $18,127,000 | +54.5% | 235,004 | +33.0% | 0.01% | +40.0% |
Q2 2018 | $11,731,000 | +30.9% | 176,746 | +3.2% | 0.01% | +25.0% |
Q1 2018 | $8,961,000 | +2.8% | 171,204 | +5.1% | 0.00% | 0.0% |
Q4 2017 | $8,721,000 | -21.8% | 162,950 | -20.6% | 0.00% | -20.0% |
Q3 2017 | $11,159,000 | +5.5% | 205,111 | +0.4% | 0.01% | 0.0% |
Q2 2017 | $10,574,000 | -17.6% | 204,302 | +0.1% | 0.01% | -16.7% |
Q1 2017 | $12,834,000 | +18.1% | 204,163 | -0.8% | 0.01% | +20.0% |
Q4 2016 | $10,863,000 | -1.0% | 205,842 | +1.3% | 0.01% | -16.7% |
Q3 2016 | $10,977,000 | +28.2% | 203,256 | -4.0% | 0.01% | +20.0% |
Q2 2016 | $8,560,000 | +16.8% | 211,825 | +1.4% | 0.01% | +25.0% |
Q1 2016 | $7,326,000 | +8.8% | 208,840 | +39.2% | 0.00% | 0.0% |
Q4 2015 | $6,736,000 | -6.5% | 150,072 | -19.7% | 0.00% | -20.0% |
Q3 2015 | $7,206,000 | -18.1% | 186,935 | +2.9% | 0.01% | 0.0% |
Q2 2015 | $8,794,000 | +50.2% | 181,735 | +9.7% | 0.01% | +25.0% |
Q1 2015 | $5,856,000 | +11.9% | 165,646 | +1.7% | 0.00% | +33.3% |
Q4 2014 | $5,234,000 | -9.1% | 162,877 | +5.3% | 0.00% | -25.0% |
Q3 2014 | $5,756,000 | -4.9% | 154,726 | -2.2% | 0.00% | 0.0% |
Q2 2014 | $6,054,000 | -13.4% | 158,222 | +3.2% | 0.00% | -20.0% |
Q1 2014 | $6,990,000 | +14.0% | 153,372 | -0.2% | 0.01% | 0.0% |
Q4 2013 | $6,131,000 | -8.5% | 153,672 | +0.5% | 0.01% | -16.7% |
Q3 2013 | $6,700,000 | +48.3% | 152,885 | +6.4% | 0.01% | +50.0% |
Q2 2013 | $4,519,000 | – | 143,632 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |